AIFF - fireflyneuro.com Profit before interest, taxes and amortization
Firefly Neuroscience, Inc (AIFF) is expanding its AI-driven dementia diagnostics, aiming for leadership in neuropharmaceuticals via the B2B segment. The change in EBITDA reflects cash flow dynamics, with the metric currently standing at 0.00. The company is implementing ethical data standards and cloud infrastructure. The high scaling potential of the software following FDA approval is currently limited by the initial size of the client base.
Firefly Neuroscience - analytical breakdowns and key metrics (AIFF)
- stock quotes and analyst forecast:
- market capitalization statistics:
- book capitalization data:
- business debt structure and liquidity details:
Debt to Capital Firefly Neuroscience, Inc|AIFF - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Firefly Neuroscience, Inc.|AIFF - Company Debts|Debt to Book Value Ratio Firefly Neuroscience|AIFF - Company Long-Term Debts|Short-Term Debt Firefly Neuroscience|Quick Ratio fireflyneuro.com
- earnings and valuation multiples information:
AIFF - Company Net Income|Expected Net Income Firefly Neuroscience, Inc|AIFF - Price to Earnings Ratio|Projected Price to Earnings Ratio fireflyneuro.com|AIFF - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Firefly Neuroscience|AIFF - Operating profit EBITDA|Net earnings per share for the last 12 months Firefly Neuroscience|AIFF - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months fireflyneuro.com|AIFF - Earnings growth in current year|Expected net earnings per share growth next year Firefly Neuroscience, Inc
Analysis of all company metrics:Firefly Neuro - AIFF
This metric reflects the operational efficiency of the business by measuring earnings before interest, taxes, depreciation, and amortization, allowing for an assessment of the company's actual ability to generate cash flow. By analyzing absolute EBITDA, an investor can gauge the maturity of the processes at Firefly Neuroscience, Inc (AIFF), whose AI software development model for EEG minimizes capital expenditures due to the absence of industrial impact and the transition to energy-efficient cloud technologies.
Who Firefly Neuroscience, Inc competes with
Income before deduction of interest, taxes and amortization BIIB|Neurocrine Biosciences - Operating profit EBITDA|Profit before interest, taxes and amortization regencellbioscience.com|AXSM: Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization ACAD (ACADIA Pharma)|Profit before payment of interest, taxes and amortization Xenon Pharmaceuticals Inc|Profit before payment of interest, taxes and amortization VKTX|Operating profit before deduction of amortization SUPN (Supernus Pharmaceuticals)|CPRX - Profit before interest, taxes and amortization|Denali Therapeutics Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization HRMY|BHVN - Profit before payment of interest, taxes and amortization|AMLX (Amylyx Corp) - Operating profit before amortization|TRVI: Operating profit EBITDA|Profit before interest, taxes and amortization praxismedicines.com (PRAX)|Operating profit before deduction of amortization AVXL|Operating profit EBITDA CeriBell Inc|Profit before payment of interest, taxes and amortization Prothena Corp (PRTA)|ALEC (alector.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Annexon, Inc. ANNX|Omeros Corp (OMER) - Profit before interest, taxes and amortization|NGNE - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization AC Immune S.A. ACIU|VYGR: Operating profit EBITDA|Operating profit before deduction of amortization Neumora Corp|SCLX (Scilex Holding Company) - Operating profit EBITDA|tevogen.com (TVGN) - Operating income before deduction of amortization|Operating profit EBITDA ACOG|CGTX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Inhibikase IKT|SAVA: Operating profit before amortization|Assertio Therapeutics - Operating profit EBITDA|Coya Therapeutics, Inc. (COYA) - Operating profit before deduction of amortization|VTGN: Operating profit EBITDA|Profit before interest, taxes and amortization Ovid Therapeutics (OVID)|Operating profit before deduction of amortization ABOS|CRVO: Income before deduction of interest, taxes and amortization|Operating profit EBITDA ATHE|Operating income before deduction of amortization clene.com|Profit before payment of interest, taxes and amortization PepGen PEPG|JUNS: Operating profit before amortization|Relmada - Operating profit EBITDA|Annovis Bio Corporation (ANVS) - Operating profit before deduction of amortization|GRCE: Operating profit EBITDA|Klotho Neurosciences (KLTO) - Operating profit EBITDA|NRSN (NeuroSense Therapeutics Ltd) - Operating profit EBITDA|Reviva Pharmaceuticals Holdings Inc. (RVPH) - Operating income before deduction of amortization|Operating profit EBITDA MTVA|NRXS: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA HSDT (Helius Medical Technologies)|PASG (Passage Bio Inc.) - Profit before deduction of interest, taxes, depreciation and amortization|NEUP - Profit before payment of interest, taxes and amortization|NERV (Minerva Neurosciences Inc) - Operating profit before amortization|ATHA: Operating profit EBITDA|Profit before interest, taxes and amortization Addex (ADXN)|Operating profit before deduction of amortization ALZN|Operating profit EBITDA Cyclerion|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Cortigent CRGT|Avenue Therapeutics Inc (ATXI) - Profit before interest, taxes and amortization|Brainstorm Cell - Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization CARA|CHRO: Operating profit EBITDA|ELYM - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Intra-Cellular Therapies Inc.|LBPH: Income before deduction of interest, taxes and amortization|Operating profit EBITDA MRNS|NKGN - Profit before interest, taxes and amortization|Operating profit EBITDA NRBO (NeuroBo Pharmaceuticals, Inc.)|SAGE (Sage Therapeutics Inc.) - Profit before deduction of interest, taxes, depreciation and amortization|SNPX - Profit before payment of interest, taxes and amortization|TRVN: Profit before payment of interest, taxes and amortization|VIGL (vigilneuro.com) - Operating profit before deduction of amortization|Profit before interest, taxes and amortization anewmeds.com (WENA)|Operating profit before deduction of amortization CERE
